Avoiding harm in peritoneal dialysis patients

Advances in Chronic Kidney Disease
Filitsa H Bender

Abstract

This review is focused on minimizing complications and avoiding harm in peritoneal dialysis (PD) patients. Issues related to planning for PD are covered first, with emphasis on PD versus hemodialysis outcomes. Catheter types and insertion techniques are described next, including relevant recommendations by the International Society for Peritoneal Dialysis. A brief review of both noninfectious and infectious complications follows, with emphasis on cardiovascular and metabolic complications. Finally, recommendations for preventing PD-related infections are provided. In conclusion, with proper catheter insertion technique, good training, and attention to detail during the tenure in PD, excellent outcomes can be obtained in a well-informed motivated patient.

References

Mar 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A GreenbergJ A Perlmutter
Sep 1, 1987·Annals of Internal Medicine·J D HarnettH Gault
Dec 10, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A J CollinsJ Z Ma
Oct 9, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·T Golper
Jan 5, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nancy G KutnerSteven A Cole
Sep 13, 2003·Seminars in Dialysis·Kai Ming ChowPhilip Kam-Tao Li
Oct 22, 2003·Journal of the American Society of Nephrology : JASN·Fabian TermorshuizenUNKNOWN Netherlands Cooperative Study on the Adequacy of Dialysis Study Group
Apr 28, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kitty J JagerUNKNOWN Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group
Sep 24, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Giovanni F M StrippoliJonathan C Craig
Jan 22, 2005·Seminars in Dialysis·John Burkart
May 28, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Tony GoovaertsEric Goffin
Jul 22, 2005·The New England Journal of Medicine·Christoph WannerUNKNOWN German Diabetes and Dialysis Study Investigators
Jan 25, 2006·Clinical Nephrology·S PanagoutsosV Vargemezis
Oct 25, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·David W JohnsonDavid L Nicol
Nov 3, 2006·Kidney International. Supplement·S S Prichard
Nov 3, 2006·Kidney International. Supplement·J H Crabtree
Nov 3, 2006·Kidney International. Supplement·F H BenderB Piraino
Dec 1, 2006·Kidney International·Y S LiemW C Winkelmayer
Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Joanne M Bargman
Dec 19, 2008·Journal of the American Society of Nephrology : JASN·Stephen P McDonaldKevan R Polkinghorne
Apr 1, 2009·The New England Journal of Medicine·Bengt C FellströmUNKNOWN AURORA Study Group
Jan 23, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Kunal Chaudhary, Ramesh Khanna
Jul 16, 2010·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Philip Kam-Tao LiUNKNOWN International Society for Peritoneal Dialysis
Jul 16, 2010·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Ana FigueiredoUNKNOWN International Society for Peritoneal Dialysis
Sep 30, 2010·Archives of Internal Medicine·Rajnish MehrotraEdward Vonesh
Nov 3, 2010·Journal of the American College of Surgeons·Vikram AttaluriSteven Rosenblatt
Mar 29, 2011·Seminars in Nephrology·Sharon J Nessim
Apr 23, 2011·Journal of the American Society of Nephrology : JASN·Jeffrey PerlLouise Moist
Jul 26, 2011·Journal of the American Society of Nephrology : JASN·Robert R QuinnAndreas Laupacis
Aug 30, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jingyuan XieNan Chen
Sep 2, 2011·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Beth PirainoCheuk-Chun Szeto
Oct 25, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Arshia Ghaffari
Dec 14, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Miklos Z MolnarKamyar Kalantar-Zadeh
Mar 7, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Karen YeatesStanley Fenton

❮ Previous
Next ❯

Citations

Jan 16, 2020·Revista da Associação Médica Brasileira·Maria Claudia Cruz Andreoli, Claudia Totoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Marlies Noordzij, Kitty J Jager
Advances in Chronic Kidney Disease
Ramapriya Sinnakirouchenan, J L Holley
International Journal of Cardiology
Mohit Turagam, Poonam Velagapudi
© 2021 Meta ULC. All rights reserved